Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 1,212 people who get email alerts on JAZZ.

Get email alerts on JAZZ »

Market Currents

Jazz Pharmaceuticals (JAZZ) is now down 5.1% AH following the announcement of its merger with...

Monday, September 19, 2011, 4:48 PM ET
Jazz Pharmaceuticals (JAZZ) is now down 5.1% AH following the announcement of its merger with Azur Pharma.

This Market Current was sent to 1,212 people who get email alerts on JAZZ.

Get email alerts on JAZZ »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles

Follow The 'Smart Money' And Buy Johnson & Johnson In The Next Pullback
3:48 PM • Hawkinvest
Why Merck Shares Are Cheap And Could Rise To $60
3:41 PM • Trade In Mexico
Arena Is Still A Great Short
3:08 PM • EnhydrisPECorp
Expanding Use Of Alexion's Specialty Drug Soliris Offers Upside
1:23 PM • Todd Campbell
Arena Buyout More 'Highly Probable' Than MannKind
1:20 PM • Chris_Roberts
Another Look At Marketing Vs. R&D In Pharma
11:29 AM • Derek Lowe
Thoratec, A Bio Stock With Good Potential And Products
8:48 AM • StockRiters
Abbott Laboratories: Undervalued Potential
8:48 AM • Fundamental Analyst
Zalicus Awaiting Data On Potential New Pain Medication
8:19 AM • Len Zehr
MannKind's Afrezza And The Oramed Threat
8:10 AM • Cory Renauer
Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Rates
6:30 AM • Robert Honeywill
Intuitive Surgical: Years Of Super Growth Ahead
6:30 AM • Fundamental Investor
Will Arena's Belviq Be The Next Anti-Obesity Drug To Make The Cover Of Time Magazine?
2:49 AM • Reasonable Risk
Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability
11:06 PM • Jacob Smith
Medtronic's Defibrillator Sales Show A Pulse With Encouraging Results
7:21 PM • Trefis

More Latest Articles »